LIBERTY is part of the Company’s broader REVOLUTION clinical program designed to elaborate the profile of monoclonal antibody-mediated prophylaxis from COVID-19 and the potential medical benefits to ...
As bird flu continues to circulate in animals and spill over into humans, researchers are racing to stop it before it adapts ...
Iowa and Indiana have recently introduced legislation that would establish new registration and licensure requirements for medical spas. Iowa ...
The Casppian study design included periodic evaluations and long-term safety monitoring for up to a total of 12 months following the first injection. -- There has been no safety concern with the use ...
The woman's prolonged dizziness was solved by a Hyderabad neurologist, Dr Sudhir Kumar, who found she had a deficiency due to ...
This is the third program that successfully combines Entera's oral peptide N-Tab- platform with OPKO's advanced protein chemistry capabilities The companies have accelerated this program and aim to ...
Annexin Pharmaceuticals AB today announces favourable findings in the company's ongoing Proof of Concept Phase 2a study with the drug candidate ANXV in Diabetic Retinopathy (DR) and Retinal Vein Occlu ...
Everyday Health on MSN
Predicting how long the menopausal transition will last and when you’ll reach menopause: Questions and answers
It’s hard to predict when you’ll reach menopause, how symptoms will affect you, and how long they’ll last, but your genes and ...
The history of the hepatitis B vaccine has been marked by controversies, from the ‘Australia antigen’ to the ‘Pediatric ...
Investors have responded positively to this operational progress. Teva's stock closed yesterday on the New York exchange at $36.25, marking a daily gain of just over two percent. This advance brings ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results